View in EDS HTML Full Text PDF Full Text

Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection.

Saved in:
Bibliographic Details
Title: Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection.
Authors: Sulkowski, M. S.1 msulkowski@jhmi.edu, Feld, J. J.2, Lawitz, E.3, Felizarta, F.4, Corregidor, A. M.5, Khalid, O.6, Ghalib, R.7, Smith, W. B.8, Van Eygen, V.9, Luo, D.10, Vijgen, L.9, Gamil, M.9, Kakuda, T. N.11, Ouwerkerk‐Mahadevan, S.9, Van Remoortere, P.10, Beumont, M.9
Source: Journal of Viral Hepatitis. Jun2018, Vol. 25 Issue 6, p631-639. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13520504
DOI:10.1111/jvh.12853